P342: BASELINE GENE EXPRESSION ANALYSIS OF RELAPSED ACUTE B-LYMPHOBLASTIC LEUKEMIA PATIENTS TREATED WITH INOTUZUMAB OZOGAMICIN

Podobne zapisy

• P558: ABSOLUTE LYMPHOCYTE COUNT IS AN INDEPENDENT SURVIVAL PREDICTOR COMPARED TO MINIMAL RESIDUAL DISEASE IN PATIENTS WITH ACUTE MYELOID LEUKEMIA TREATED WITH INTENSIVE CHEMOTHERAPY
  od: Gianluca Cristiano, i wsp.
  Wydane: (2023-08-01)
• P070 | ABSOLUTE LYMPHOCYTE COUNT AND IMMUNE TRANSCRIPTOMIC BONE MARROW PROFILE AS NOVEL PROGNOSTIC PREDICTORS IN PATIENTS WITH ACUTE MYELOID LEUKEMIA TREATED WITH INTENSIVE CHEMOTHERAPY
  od: G. Cristiano, i wsp.
  Wydane: (2025-09-01)
• P342: BASELINE GENE EXPRESSION ANALYSIS OF RELAPSED ACUTE B-LYMPHOBLASTIC LEUKEMIA PATIENTS TREATED WITH INOTUZUMAB OZOGAMICIN
  od: C. Sartor, i wsp.
  Wydane: (2022-06-01)
• PB1744: THE RATIO OF ABSOLUTE LYMPHOCYTE COUNT AT INTERIM OF THERAPY TO ABSOLUTE LYMPHOCYTE COUNT AT DIAGNOSIS PREDICTS SURVIVAL IN ACUTE LYMPHOBLASTIC LEUKEMIA
  od: Talbi Faiza, i wsp.
  Wydane: (2023-08-01)
• The Predictive Value of Absolute Lymphocyte Count and T Cell Subpopulations for Sepsis Prognosis
  od: Jia X, i wsp.
  Wydane: (2024-11-01)